Clinical Trial Update: Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy [NA]

View source ↗

Summary

This clinical trial is evaluating the efficacy and safety of low-dose Conbercept for treating Retinopathy of Prematurity and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Wang Yusheng | Conditions: Retinopathy of Prematurity (ROP) | NA | Status: RECRUITING